25 results
Thumbnail

D2.283 - Beyond the skin. A rare case of contact angioedema due to Methylisothiazolinone

Thumbnail

D2.292 - Epinephrine Nasal Powder - a sustainable and reliable option for the treatment of anaphylaxis

Thumbnail

D2.293 - Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients

Thumbnail

D2.278 - National Survey on Perioperative Hypersensitivity Reactions: Evaluating Practices and Challenges in Spanish Hospitals

Thumbnail

D2.279 - In an emergency, can YOU really give that adrenaline pen? – the need for structured, further and improved training in Ireland

Thumbnail

D2.282 - IgE-mediated anaphylaxis to quinine confirmed with a basophil activation test

Thumbnail

D2.284 - Eat the fruit, do not swallow the seed: A rare case of Cucurbitaceae allergy causing anaphylaxis

Thumbnail

D2.286 - A case of prawn induced FDEIA

Thumbnail

D2.287 - Evaluation of NSAID Hypersensitivity in Children: A Retrospective Analysis

Thumbnail

D2.288 - Idursulfase Hypersensitivity Reactions: Unpacking Immunological Mechanisms Beyond Clinical Manifestations

Thumbnail

D2.289 - A Cardiovascular Enigma in the Emergency Room

Thumbnail

D2.290 - Allergens involved in a case report of anaphylaxis to ginger (Zingiber officinale), a very rare but severe allergy

Thumbnail

D2.291 - The level of knowledge of adolescent and young adults about food allergies and anaphylaxis: Key information that can save lives - a pilot study

Thumbnail

D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Thumbnail

D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Thumbnail

D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117

Thumbnail

D2.354 - Questionnaire survey of new treatments for atopic dermatitis

Thumbnail

D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Thumbnail

D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria

Thumbnail

D2.357 - Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience